Source: Cancer Gene Therapy. Unidades: HU, FMRP, FSP
Subjects: IMUNOTERAPIA, DNA, CARCINOMA
ABNT
MICHALUART, P. et al. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Gene Therapy, v. 15, n. 10, p. 676-684, 2008Tradução . . Disponível em: https://doi.org/10.1038/cgt.2008.35. Acesso em: 06 nov. 2024.APA
Michaluart, P., Abdallah, K. A., Lima, F. D., Smith, R., Moysés, R. A., Coelho, V., et al. (2008). Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Gene Therapy, 15( 10), 676-684. doi:10.1038/cgt.2008.35NLM
Michaluart P, Abdallah KA, Lima FD, Smith R, Moysés RA, Coelho V, Victora GD, Socorro-Silva A, Volsi EC, Zárate-Bladés CR, Ferraz AR, Barreto AK, Chammas MC, Gomes R, Gebrim E, Arakawa-Sugueno L, Fernandes KP, Lotufo PA, Cardoso MR, Kalil J, Silva CL. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck [Internet]. Cancer Gene Therapy. 2008 ; 15( 10): 676-684.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/cgt.2008.35Vancouver
Michaluart P, Abdallah KA, Lima FD, Smith R, Moysés RA, Coelho V, Victora GD, Socorro-Silva A, Volsi EC, Zárate-Bladés CR, Ferraz AR, Barreto AK, Chammas MC, Gomes R, Gebrim E, Arakawa-Sugueno L, Fernandes KP, Lotufo PA, Cardoso MR, Kalil J, Silva CL. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck [Internet]. Cancer Gene Therapy. 2008 ; 15( 10): 676-684.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/cgt.2008.35